0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$40.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
HCG is a glycoprotein hormone structurally analogous to endogenous luteinizing hormone, binding LH receptors on Leydig cells to initiate receptor-mediated intracellular signaling cascades in experimental models. Unlike upstream HPG axis modulators operating through hypothalamic or pituitary intermediaries, HCG enables investigation of LH receptor-specific signaling behavior in isolation from upstream regulatory variables. This direct receptor engagement profile supports mechanistic characterization of LH receptor occupancy kinetics, downstream cAMP-mediated signaling cascade dynamics, and receptor-linked molecular marker activity in preclinical Leydig cell experimental systems.
HCG supports investigation of gonadotropin receptor-mediated signaling dynamics across testicular and ovarian tissue experimental models. Research applications include characterization of LH receptor interaction behavior, receptor sensitivity parameters, and downstream intracellular signaling pathway marker expression under defined experimental exposure conditions. Comparative study designs employing HCG alongside upstream HPG axis modulators enable systematic molecular endpoint differentiation between direct LH receptor agonism and GnRH-mediated gonadotropin release pathway signaling dynamics.
Novera supplies HCG 5000iu sourced from USA GMP-certified manufacturing facilities, independently verified to approximately 99% purity by third-party COA documentation. Each vial confirms glycoprotein hormone sequence identity, purity grade, and batch-specific quality control data — providing research laboratories with consistent, pharmaceutical-grade LH receptor agonist material for advanced gonadotropin receptor interaction and signal transduction research.
HCG 5000iu is suited for research teams and reproductive endocrinology laboratories investigating LH receptor interaction dynamics, receptor occupancy parameters, and downstream intracellular signaling pathway marker characterization in controlled preclinical models. Scientists examining LH receptor binding affinity, cAMP-mediated signal transduction dynamics, and receptor-specific molecular endpoint behavior in Leydig cell experimental systems will find HCG relevant to mechanistic gonadotropin receptor pharmacology study designs.
Research programs requiring a structurally defined direct LH receptor agonist reference compound for comparative receptor pharmacology investigations alongside upstream HPG axis modulators such as Kisspeptin or Gonadorelin benefit from HCG’s distinct receptor-level activation profile. Laboratories studying gonadotropin receptor signaling behavior, receptor sensitivity dynamics, and pathway-level molecular differentiation in reproductive tissue experimental models will find HCG well-suited to multi-arm gonadotropin signaling research designs. Novera supplies HCG 5000iu sourced from USA GMP-certified manufacturing facilities, with each vial COA-verified for purity and potency to approximately 99%.
HCG supports in vitro and ex vivo investigation of LH receptor occupancy dynamics, receptor binding affinity parameters, and downstream intracellular signaling cascade activation in Leydig cell experimental models. Researchers characterizing cAMP second messenger pathway activity and receptor-linked molecular marker dynamics following direct LH receptor engagement use HCG as a reference compound for mechanistic gonadotropin receptor pharmacology study designs.
Laboratories studying LH receptor-mediated signal transduction use HCG to quantify downstream intracellular molecular marker activity, second messenger signaling cascade dynamics, and receptor-linked pathway behavior in controlled preclinical Leydig cell model systems. Multi-arm protocols comparing direct LH receptor agonist and upstream GnRH-mediated gonadotropin release downstream signaling profiles support mechanistic characterization of pathway-specific molecular endpoint differentiation.
HCG’s direct LH receptor activation profile enables multi-arm comparative study designs examining how direct gonadotropin receptor agonism produces distinct downstream intracellular signaling pathway marker patterns relative to upstream HPG axis modulators such as Kisspeptin or Gonadorelin. Research quantifying molecular endpoint differences between direct receptor engagement and upstream pathway modulation contributes to mechanistic understanding of gonadotropin signaling biology in preclinical models.
Reconstitute lyophilized HCG 5000iu with sterile bacteriostatic water using standard sterile laboratory technique. Reconstitution volume should be determined based on the target experimental working concentration specified by the study design. Research protocols examining LH receptor sensitivity dynamics and steroidogenic pathway marker progression typically employ defined administration intervals with systematic endpoint monitoring; document each reconstitution step in accordance with institutional research record-keeping standards. Use calibrated laboratory equipment throughout all preparation steps.
Store lyophilized glycoprotein hormone at 2–8°C, protected from light and moisture, prior to reconstitution. Following reconstitution, maintain strict refrigeration at 2–8°C; reconstituted hormone remains stable for use within the timeframe specified in accompanying experimental documentation. This product does not require cold-chain shipping, but immediate refrigeration upon receipt is recommended to preserve glycoprotein hormone structural integrity and biological activity throughout the protocol period. Each vial supplied by Novera includes COA documentation and handling guidance.
Preclinical reproductive endocrinology studies using HCG span a broad range depending on experimental objectives — from short-term acute LH receptor activation and binding kinetics investigations through extended multi-week steroidogenic pathway marker progression and receptor sensitivity characterization protocols. Initial measurable downstream Leydig cell signaling marker responses in preclinical models may be observed within days of administration. Monitor LH receptor pathway activity markers, downstream steroidogenic enzyme expression dynamics, gonadotropin-dependent reproductive pathway markers, and receptor sensitivity indicators at defined experimental intervals throughout the observation period, in accordance with institutional laboratory standards.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade dual-peptide formulation combining two synthetic peptides for streamlined laboratory peptide research protocols.
Research-grade synthetic peptide fragment formulated for advanced laboratory peptide research and experimental scientific protocols. Disclosure: This product is intended for research purposes only and is not intended for human consumption...
A synthetic GHRH analog studied for receptor binding kinetics, molecular interaction modeling, and pulsatile signaling pathway investigation in preclinical settings.
Explore GHK-CU BPC-157 Tb-500 KPV Klow Blend, Novera's most advanced peptide blend. This superior four-peptide formula delivers unmatched benefits for skin and tissue repair, inflammatory balance, and rapid recovery.
